Close



Apr 18, 2024 07:01AM
Apr 18, 2024 07:00AM
Apr 16, 2024 07:03AM
Apr 16, 2024 07:00AM
Apr 6, 2024 10:00AM
Mar 11, 2024 04:11PM
Mar 11, 2024 04:05PM Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2023 Results
Mar 5, 2024 07:30AM
Feb 22, 2024 07:32AM
Feb 22, 2024 07:30AM
Feb 15, 2024 08:01AM
Feb 15, 2024 08:00AM
Feb 13, 2024 07:37AM
Jan 25, 2024 08:01AM Ocular Therapeutix (OCUL) Announces FDA Agreement to Amend Special Protocol Assessment for Trial of AXPAXLI
Jan 25, 2024 08:00AM
Nov 7, 2023 04:06PM
Nov 7, 2023 04:01PM
Nov 1, 2023 08:02AM
Nov 1, 2023 08:00AM
Oct 24, 2023 08:00AM
Oct 3, 2023 04:01PM Ocular Therapeutix™ Announces Initiation of its First Pivotal Clinical Trial of OTX-TKI in Wet AMD
Aug 7, 2023 04:05PM
Aug 7, 2023 04:01PM
Jul 24, 2023 08:00AM
May 8, 2023 04:26PM
May 8, 2023 04:01PM
Apr 24, 2023 08:00AM
Mar 6, 2023 04:02PM Ocular Therapeutix (OCUL) Tops Q4 EPS by 1c
Mar 6, 2023 04:02PM
Mar 6, 2023 04:01PM
Feb 21, 2023 08:00AM
Jan 6, 2023 08:00AM
Nov 7, 2022 04:01PM
Oct 24, 2022 06:00AM
Aug 8, 2022 04:01PM Ocular Therapeutix™ Reports Second Quarter 2022 Financial Results and Business Update
Jul 25, 2022 08:00AM
May 9, 2022 04:45PM
May 9, 2022 04:01PM
Apr 26, 2022 08:00AM
Feb 28, 2022 04:48PM
Feb 28, 2022 04:01PM
Feb 22, 2022 08:00AM Ocular Therapeutix™ To Report Fourth Quarter and Year-End 2021 Financial Results
Nov 8, 2021 04:34PM
Nov 8, 2021 04:01PM
Oct 29, 2021 04:01PM
Aug 9, 2021 04:54PM
Aug 9, 2021 04:01PM
Jul 28, 2021 08:00AM
Jul 22, 2021 04:08PM Ocular Therapeutix (OCUL) Q2 Preliminary Net Product Revenue Surges 600% to $11.7M
Jul 22, 2021 04:01PM

976,210 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All